Gemcitabine Therapy in Patients with Advanced Pancreatic Cancer
Young Joo Min, Kwang Ro Joo, Neung Hwa Park, Tae Kwon Yun, Yang Won Nah, Chang Woo Nam, Jae Hoo Park
Korean J Intern Med. 2002;17(4):259-262.   Published online 2002 Dec 1     DOI:
Citations to this article as recorded by Crossref logo
p21-activated kinase signalling in pancreatic cancer: New insights into tumour biology and immune modulation
Kai Wang, Graham S Baldwin, Mehrdad Nikfarjam, Hong He
World Journal of Gastroenterology.2018; 24(33): 3709.     CrossRef
A Comparative Quantitative LC-MS/MS Profiling Analysis of Human Pancreatic Adenocarcinoma, Adjacent-Normal Tissue, and Patient-Derived Tumour Xenografts
Orla Coleman, Michael Henry, Fiona O'Neill, Sandra Roche, Niall Swan, Lorraine Boyle, Jean Murphy, Justine Meiller, Neil Conlon, Justin Geoghegan, Kevin Conlon, Vincent Lynch, Ninfa Straubinger, Robert Straubinger, Gerard McVey, Michael Moriarty, Paula Me
Proteomes.2018; 6(4): 45.     CrossRef
Therapeutic Potential of Curcumin in Treatment of Pancreatic Cancer: Current Status and Future Perspectives
Mina Hosseini, Seyed Mahdi Hassanian, Elham Mohammadzadeh, Soodabeh ShahidSales, Mina Maftouh, Hasan Fayazbakhsh, Majid Khazaei, Amir Avan
Journal of Cellular Biochemistry.2017; 118(7): 1634.     CrossRef
Clinical outcomes following stereotactic body radiation therapy (SBRT) for non-resectable pancreatic adenocarcinoma
Raj Singh, Hayden Ansinelli, Sanjeev Sharma
Journal of Radiation Oncology.2017; 6(3): 279.     CrossRef
Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies
Aleksandra Adamska, Alice Domenichini, Marco Falasca
International Journal of Molecular Sciences.2017; 18(7): 1338.     CrossRef
Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study
Kyung Hee Lee, Min Kyoung Kim, Yeol Hong Kim, Baek Yeol Ryoo, Ho Yeong Lim, Hong Suk Song, Hoon Kyo Kim, Myung Ah Lee, Seock Ah Im, Heung Moon Chang, Jae Yong Cho, Dae Young Zang, Bong Seog Kim, Jun Suk Kim
Cancer Chemotherapy and Pharmacology.2009; 64(2): 317.     CrossRef
Fixed Dose Rate Infusion of Gemcitabine with Oral Doxifluridine and Leucovorin for Advanced Unresectable Pancreatic Cancer: A Phase II Study
Hawk Kim, Jae-Hoo Park, Su Jin Shin, Mee-Ja Kim, Sung-Jo Bang, Neung Hwa Park, Yang Won Nah, Chang Woo Nam, Kwang Ro Joo, Young Joo Min
Chemotherapy.2008; 54(1): 54.     CrossRef